Loading clinical trials...
Loading clinical trials...
Antiproteinuric Effects of Liraglutide Treatment in Patients With Type 2 Diabetes and Albuminuria: A Randomised, Placebo-Controlled Trial
Conditions
Interventions
Liraglutide
placebo
Locations
1
Denmark
Peter Rossing
Gentofte Municipality, Denmark
Start Date
April 1, 2015
Primary Completion Date
May 1, 2016
Completion Date
May 1, 2016
Last Updated
August 10, 2016
NCT07271186
NCT06600412
NCT05822609
NCT06291155
NCT06441591
NCT04802395
Lead Sponsor
Steno Diabetes Center Copenhagen
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions